In the present study, we investigated the relationships between several molecular properties and bioavailability data for seven of the most commonly prescribed angiotensin II receptor antagonists (also known as angiotensin II receptor blockers (ARBs) or sartans), candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan and valsartan. The molecular descriptors of ARBs are:, aqueous solubility (logS values), polar surface area (PSA), molecular weight (Mw), volume value (Vol), lipophilicity (logP values) and the acidity descriptor (pKa1). The respective descriptors were calculated using four different software packages. The relevant bioavailability data were obtained from literature. Among calculated mo...
The QSAR analysis is aimed at identification of structural patterns responsible for manifestation of...
Aim. To present a scientific review of angiotensin II (AT II) receptor blockers (sartans) clinical p...
Calcium channel blockers are commonly prescribed antihypertensive drugs. In this study, nine calcium...
In the present study, we investigated the relationships between several molecular properties and bio...
Abstract- Angiotensin II receptor antagonists (ARBs) modulate the function of the renin-angiotensin-...
Angiotensin II receptor antagonists (ARBs) modulate the function of the renin-angiotensin-aldoste...
Angiotensin II receptor antagonists (ARAs) are one of the most promising classes of antihypertensive...
This article reviews the pharmacokinetics and pharmacodynamics of angiotensin II (AII) receptor anta...
This article reviews the pharmacokinetics and pharmacodynamics of angiotensin II (AII) receptor anta...
The discovery of new pharmacologically active substances and drugs modeling led to necessity of pred...
Several angiotensin II receptor blockers (ARB) are currently available for the treatment of hyperten...
The pharmacokinetic and pharmacodynamic properties of nonpeptide angiotensin antagonists in humans a...
This study was designed to examine the interaction in the binding of selective angiotensin II recept...
Introduction: Irbesartan (CAS registry: 138402-11-6) is a potent, orally active, selective antagonis...
Several orally active non-peptide angiotensin II subtype 1 (AT1) receptor antagonists are now availa...
The QSAR analysis is aimed at identification of structural patterns responsible for manifestation of...
Aim. To present a scientific review of angiotensin II (AT II) receptor blockers (sartans) clinical p...
Calcium channel blockers are commonly prescribed antihypertensive drugs. In this study, nine calcium...
In the present study, we investigated the relationships between several molecular properties and bio...
Abstract- Angiotensin II receptor antagonists (ARBs) modulate the function of the renin-angiotensin-...
Angiotensin II receptor antagonists (ARBs) modulate the function of the renin-angiotensin-aldoste...
Angiotensin II receptor antagonists (ARAs) are one of the most promising classes of antihypertensive...
This article reviews the pharmacokinetics and pharmacodynamics of angiotensin II (AII) receptor anta...
This article reviews the pharmacokinetics and pharmacodynamics of angiotensin II (AII) receptor anta...
The discovery of new pharmacologically active substances and drugs modeling led to necessity of pred...
Several angiotensin II receptor blockers (ARB) are currently available for the treatment of hyperten...
The pharmacokinetic and pharmacodynamic properties of nonpeptide angiotensin antagonists in humans a...
This study was designed to examine the interaction in the binding of selective angiotensin II recept...
Introduction: Irbesartan (CAS registry: 138402-11-6) is a potent, orally active, selective antagonis...
Several orally active non-peptide angiotensin II subtype 1 (AT1) receptor antagonists are now availa...
The QSAR analysis is aimed at identification of structural patterns responsible for manifestation of...
Aim. To present a scientific review of angiotensin II (AT II) receptor blockers (sartans) clinical p...
Calcium channel blockers are commonly prescribed antihypertensive drugs. In this study, nine calcium...